000 01083 a2200289 4500
005 20250514032810.0
264 0 _c20020605
008 200206s 0 0 eng d
022 _a0012-3692
024 7 _a10.1378/chest.121.5_suppl.209s
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDe Boer, W I
245 0 0 _aCytokines and therapy in COPD: a promising combination?
_h[electronic resource]
260 _bChest
_cMay 2002
300 _a209S-218S p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aChemokine CCL2
_xantagonists & inhibitors
650 0 4 _aCytokines
_xantagonists & inhibitors
650 0 4 _aGlucocorticoids
_xpharmacology
650 0 4 _aHumans
650 0 4 _aInterleukin-8
_xantagonists & inhibitors
650 0 4 _aPulmonary Disease, Chronic Obstructive
_xdrug therapy
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
773 0 _tChest
_gvol. 121
_gno. 5 Suppl
_gp. 209S-218S
856 4 0 _uhttps://doi.org/10.1378/chest.121.5_suppl.209s
_zAvailable from publisher's website
999 _c11909233
_d11909233